Supplementary Tables 1-5. Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries
dataset
posted on 2021-10-20, 08:18 authored by Karl M. Kilgore, Iman Mohammadi, Anny C. Wong, Julia Thornton Snider, Paul Cheng, Amy Schroeder, Anik R. PatelSupplementary Tables 1-5. Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries
Table 1. Standard First and Second LOT Regimens1
Table 2. Qualifying Stem-cell Treatment Codes
Table 3. LBCL-Related HRU
Table 4. LBCL-Related Costs PPPM
Table 5. Adverse Event Code Sets
